Intensive vs. conventional blood pressure goals in older patients with type 2 diabetes: a systematic review and meta-analysis

Purpose Assess the effect of intensive vs conventional blood pressure goals on patient-important outcomes in older adults with type 2 diabetes. Methods A comprehensive search was performed using electronic databases. Randomized controlled trials comparing intensive vs conventional blood pressure goa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine 2022-10, Vol.78 (1), p.13-23
Hauptverfasser: Rodriguez-Gutierrez, Rene, Flores-Rodríguez, Andrea, Raygoza-Cortez, Karina, Garcia-Leal, Mariana, Mariño-Velasco, Sofía, Plata-Huerta, Hiram H., Sáenz-Flores, Melissa, Ramirez-Garcia, Luz A., Rojo-Garza, Amanda, Maraka, Spyridoula, Singh-Ospina, Naikky V., Brito, Juan P., Gonzalez-Gonzalez, Jose G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 23
container_issue 1
container_start_page 13
container_title Endocrine
container_volume 78
creator Rodriguez-Gutierrez, Rene
Flores-Rodríguez, Andrea
Raygoza-Cortez, Karina
Garcia-Leal, Mariana
Mariño-Velasco, Sofía
Plata-Huerta, Hiram H.
Sáenz-Flores, Melissa
Ramirez-Garcia, Luz A.
Rojo-Garza, Amanda
Maraka, Spyridoula
Singh-Ospina, Naikky V.
Brito, Juan P.
Gonzalez-Gonzalez, Jose G.
description Purpose Assess the effect of intensive vs conventional blood pressure goals on patient-important outcomes in older adults with type 2 diabetes. Methods A comprehensive search was performed using electronic databases. Randomized controlled trials comparing intensive vs conventional blood pressure goals in adults over 60 years of age with type 2 diabetes were included. Events were evaluated using a modified Mantel-Haenszel meta-analysis with Peto’s method. Study selection and data extraction were performed independently and in duplicate. Results Seven trials were included. A 19% risk reduction (OR 0.81; 95% CI 0.69–0.95; I 2  = 8%; p  = 0.35) in the occurrence of major adverse cardiovascular events (MACE) and 37% risk reduction (OR 0.63; 95% CI 0.51–0.79; I 2  = 0%; p  = 0.56) in the occurrence of fatal or non-fatal stroke was documented in the intensive treatment group. There were no differences in the occurrence of all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, and peripheral vascular disease. Data regarding treatment adverse effects and microvascular outcomes was scarce. Conclusions Intensive blood pressure goals in older patients with diabetes were associated with a lower risk of stroke and MACE, but not with all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, and peripheral vascular disease. Highlights This is the first review on the effect of intensive blood pressure goals in older patients who have diabetes. This analysis provides evidence that intensive blood pressure goals in older patients with diabetes are associated with a lower risk of stroke and MACE. There were no differences in all-cause mortality, CV mortality, non-fatal myocardial infarction, and peripheral vascular disease. The pros and cons of an intensive approach should be discussed with patients given that it could increase the number of medications, cost, and adverse events. Clinicians should address these results with caution, as the estimates are not robust enough to recommend a specific blood pressure goal due to the heterogeneity of goals and interventions among the included studies.
doi_str_mv 10.1007/s12020-022-03159-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2702183438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2702183438</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-3c15687bffa826e4fd8e5e58f1b51543686b1073a4ee49be45b2042ec610d6623</originalsourceid><addsrcrecordid>eNp9kU1rGzEQhpeSQPP1B3Ia6KWXTUbSfuZWTD8ChlySs9Duzroya2mjkR18yH-PHBdSeuhJA3reh2HeLLsWeCMQ61sWEiXmKGWOSpRt3n7KzkSZBkz_J3_Nn7Nz5jUmUlb1WfZ67yI5tjuCHd9A792OXLTemQm6yfsB5kDM20Cw8mZisA78NFCA2USbUIYXG39D3M8EEgZrOorEd2CA9xxpk6geAu0svYBxA2womtwk_Z4tX2anY5LS1Z_3Inv68f1x8StfPvy8X3xb5r1CFXPVi7Jq6m4cTSMrKsahoZLKZhRdKcpCVU3VCayVKYiKtqOi7CQWkvpK4FBVUl1kX4_eOfjnLXHUG8s9TZNx5LesZY1SNKpQTUK__IOu_TakfQ-UKGqF2B6E8kj1wTMHGvUc7MaEvRaoD43oYyM63Vm_N6LbFFLHECfYrSh8qP-TegOcfo76</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2714730092</pqid></control><display><type>article</type><title>Intensive vs. conventional blood pressure goals in older patients with type 2 diabetes: a systematic review and meta-analysis</title><source>Springer Nature - Complete Springer Journals</source><creator>Rodriguez-Gutierrez, Rene ; Flores-Rodríguez, Andrea ; Raygoza-Cortez, Karina ; Garcia-Leal, Mariana ; Mariño-Velasco, Sofía ; Plata-Huerta, Hiram H. ; Sáenz-Flores, Melissa ; Ramirez-Garcia, Luz A. ; Rojo-Garza, Amanda ; Maraka, Spyridoula ; Singh-Ospina, Naikky V. ; Brito, Juan P. ; Gonzalez-Gonzalez, Jose G.</creator><creatorcontrib>Rodriguez-Gutierrez, Rene ; Flores-Rodríguez, Andrea ; Raygoza-Cortez, Karina ; Garcia-Leal, Mariana ; Mariño-Velasco, Sofía ; Plata-Huerta, Hiram H. ; Sáenz-Flores, Melissa ; Ramirez-Garcia, Luz A. ; Rojo-Garza, Amanda ; Maraka, Spyridoula ; Singh-Ospina, Naikky V. ; Brito, Juan P. ; Gonzalez-Gonzalez, Jose G.</creatorcontrib><description>Purpose Assess the effect of intensive vs conventional blood pressure goals on patient-important outcomes in older adults with type 2 diabetes. Methods A comprehensive search was performed using electronic databases. Randomized controlled trials comparing intensive vs conventional blood pressure goals in adults over 60 years of age with type 2 diabetes were included. Events were evaluated using a modified Mantel-Haenszel meta-analysis with Peto’s method. Study selection and data extraction were performed independently and in duplicate. Results Seven trials were included. A 19% risk reduction (OR 0.81; 95% CI 0.69–0.95; I 2  = 8%; p  = 0.35) in the occurrence of major adverse cardiovascular events (MACE) and 37% risk reduction (OR 0.63; 95% CI 0.51–0.79; I 2  = 0%; p  = 0.56) in the occurrence of fatal or non-fatal stroke was documented in the intensive treatment group. There were no differences in the occurrence of all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, and peripheral vascular disease. Data regarding treatment adverse effects and microvascular outcomes was scarce. Conclusions Intensive blood pressure goals in older patients with diabetes were associated with a lower risk of stroke and MACE, but not with all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, and peripheral vascular disease. Highlights This is the first review on the effect of intensive blood pressure goals in older patients who have diabetes. This analysis provides evidence that intensive blood pressure goals in older patients with diabetes are associated with a lower risk of stroke and MACE. There were no differences in all-cause mortality, CV mortality, non-fatal myocardial infarction, and peripheral vascular disease. The pros and cons of an intensive approach should be discussed with patients given that it could increase the number of medications, cost, and adverse events. Clinicians should address these results with caution, as the estimates are not robust enough to recommend a specific blood pressure goal due to the heterogeneity of goals and interventions among the included studies.</description><identifier>ISSN: 1559-0100</identifier><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-022-03159-9</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Blood pressure ; Cardiovascular diseases ; Cerebral infarction ; Clinical trials ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; Endocrinology ; Heart attacks ; Humanities and Social Sciences ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Meta-Analysis ; Microvasculature ; Mortality ; multidisciplinary ; Myocardial infarction ; Patients ; Science ; Stroke ; Vascular diseases</subject><ispartof>Endocrine, 2022-10, Vol.78 (1), p.13-23</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c303t-3c15687bffa826e4fd8e5e58f1b51543686b1073a4ee49be45b2042ec610d6623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12020-022-03159-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12020-022-03159-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Rodriguez-Gutierrez, Rene</creatorcontrib><creatorcontrib>Flores-Rodríguez, Andrea</creatorcontrib><creatorcontrib>Raygoza-Cortez, Karina</creatorcontrib><creatorcontrib>Garcia-Leal, Mariana</creatorcontrib><creatorcontrib>Mariño-Velasco, Sofía</creatorcontrib><creatorcontrib>Plata-Huerta, Hiram H.</creatorcontrib><creatorcontrib>Sáenz-Flores, Melissa</creatorcontrib><creatorcontrib>Ramirez-Garcia, Luz A.</creatorcontrib><creatorcontrib>Rojo-Garza, Amanda</creatorcontrib><creatorcontrib>Maraka, Spyridoula</creatorcontrib><creatorcontrib>Singh-Ospina, Naikky V.</creatorcontrib><creatorcontrib>Brito, Juan P.</creatorcontrib><creatorcontrib>Gonzalez-Gonzalez, Jose G.</creatorcontrib><title>Intensive vs. conventional blood pressure goals in older patients with type 2 diabetes: a systematic review and meta-analysis</title><title>Endocrine</title><addtitle>Endocrine</addtitle><description>Purpose Assess the effect of intensive vs conventional blood pressure goals on patient-important outcomes in older adults with type 2 diabetes. Methods A comprehensive search was performed using electronic databases. Randomized controlled trials comparing intensive vs conventional blood pressure goals in adults over 60 years of age with type 2 diabetes were included. Events were evaluated using a modified Mantel-Haenszel meta-analysis with Peto’s method. Study selection and data extraction were performed independently and in duplicate. Results Seven trials were included. A 19% risk reduction (OR 0.81; 95% CI 0.69–0.95; I 2  = 8%; p  = 0.35) in the occurrence of major adverse cardiovascular events (MACE) and 37% risk reduction (OR 0.63; 95% CI 0.51–0.79; I 2  = 0%; p  = 0.56) in the occurrence of fatal or non-fatal stroke was documented in the intensive treatment group. There were no differences in the occurrence of all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, and peripheral vascular disease. Data regarding treatment adverse effects and microvascular outcomes was scarce. Conclusions Intensive blood pressure goals in older patients with diabetes were associated with a lower risk of stroke and MACE, but not with all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, and peripheral vascular disease. Highlights This is the first review on the effect of intensive blood pressure goals in older patients who have diabetes. This analysis provides evidence that intensive blood pressure goals in older patients with diabetes are associated with a lower risk of stroke and MACE. There were no differences in all-cause mortality, CV mortality, non-fatal myocardial infarction, and peripheral vascular disease. The pros and cons of an intensive approach should be discussed with patients given that it could increase the number of medications, cost, and adverse events. Clinicians should address these results with caution, as the estimates are not robust enough to recommend a specific blood pressure goal due to the heterogeneity of goals and interventions among the included studies.</description><subject>Blood pressure</subject><subject>Cardiovascular diseases</subject><subject>Cerebral infarction</subject><subject>Clinical trials</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Endocrinology</subject><subject>Heart attacks</subject><subject>Humanities and Social Sciences</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Meta-Analysis</subject><subject>Microvasculature</subject><subject>Mortality</subject><subject>multidisciplinary</subject><subject>Myocardial infarction</subject><subject>Patients</subject><subject>Science</subject><subject>Stroke</subject><subject>Vascular diseases</subject><issn>1559-0100</issn><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kU1rGzEQhpeSQPP1B3Ia6KWXTUbSfuZWTD8ChlySs9Duzroya2mjkR18yH-PHBdSeuhJA3reh2HeLLsWeCMQ61sWEiXmKGWOSpRt3n7KzkSZBkz_J3_Nn7Nz5jUmUlb1WfZ67yI5tjuCHd9A792OXLTemQm6yfsB5kDM20Cw8mZisA78NFCA2USbUIYXG39D3M8EEgZrOorEd2CA9xxpk6geAu0svYBxA2womtwk_Z4tX2anY5LS1Z_3Inv68f1x8StfPvy8X3xb5r1CFXPVi7Jq6m4cTSMrKsahoZLKZhRdKcpCVU3VCayVKYiKtqOi7CQWkvpK4FBVUl1kX4_eOfjnLXHUG8s9TZNx5LesZY1SNKpQTUK__IOu_TakfQ-UKGqF2B6E8kj1wTMHGvUc7MaEvRaoD43oYyM63Vm_N6LbFFLHECfYrSh8qP-TegOcfo76</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Rodriguez-Gutierrez, Rene</creator><creator>Flores-Rodríguez, Andrea</creator><creator>Raygoza-Cortez, Karina</creator><creator>Garcia-Leal, Mariana</creator><creator>Mariño-Velasco, Sofía</creator><creator>Plata-Huerta, Hiram H.</creator><creator>Sáenz-Flores, Melissa</creator><creator>Ramirez-Garcia, Luz A.</creator><creator>Rojo-Garza, Amanda</creator><creator>Maraka, Spyridoula</creator><creator>Singh-Ospina, Naikky V.</creator><creator>Brito, Juan P.</creator><creator>Gonzalez-Gonzalez, Jose G.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20221001</creationdate><title>Intensive vs. conventional blood pressure goals in older patients with type 2 diabetes: a systematic review and meta-analysis</title><author>Rodriguez-Gutierrez, Rene ; Flores-Rodríguez, Andrea ; Raygoza-Cortez, Karina ; Garcia-Leal, Mariana ; Mariño-Velasco, Sofía ; Plata-Huerta, Hiram H. ; Sáenz-Flores, Melissa ; Ramirez-Garcia, Luz A. ; Rojo-Garza, Amanda ; Maraka, Spyridoula ; Singh-Ospina, Naikky V. ; Brito, Juan P. ; Gonzalez-Gonzalez, Jose G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-3c15687bffa826e4fd8e5e58f1b51543686b1073a4ee49be45b2042ec610d6623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood pressure</topic><topic>Cardiovascular diseases</topic><topic>Cerebral infarction</topic><topic>Clinical trials</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Endocrinology</topic><topic>Heart attacks</topic><topic>Humanities and Social Sciences</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Meta-Analysis</topic><topic>Microvasculature</topic><topic>Mortality</topic><topic>multidisciplinary</topic><topic>Myocardial infarction</topic><topic>Patients</topic><topic>Science</topic><topic>Stroke</topic><topic>Vascular diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodriguez-Gutierrez, Rene</creatorcontrib><creatorcontrib>Flores-Rodríguez, Andrea</creatorcontrib><creatorcontrib>Raygoza-Cortez, Karina</creatorcontrib><creatorcontrib>Garcia-Leal, Mariana</creatorcontrib><creatorcontrib>Mariño-Velasco, Sofía</creatorcontrib><creatorcontrib>Plata-Huerta, Hiram H.</creatorcontrib><creatorcontrib>Sáenz-Flores, Melissa</creatorcontrib><creatorcontrib>Ramirez-Garcia, Luz A.</creatorcontrib><creatorcontrib>Rojo-Garza, Amanda</creatorcontrib><creatorcontrib>Maraka, Spyridoula</creatorcontrib><creatorcontrib>Singh-Ospina, Naikky V.</creatorcontrib><creatorcontrib>Brito, Juan P.</creatorcontrib><creatorcontrib>Gonzalez-Gonzalez, Jose G.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodriguez-Gutierrez, Rene</au><au>Flores-Rodríguez, Andrea</au><au>Raygoza-Cortez, Karina</au><au>Garcia-Leal, Mariana</au><au>Mariño-Velasco, Sofía</au><au>Plata-Huerta, Hiram H.</au><au>Sáenz-Flores, Melissa</au><au>Ramirez-Garcia, Luz A.</au><au>Rojo-Garza, Amanda</au><au>Maraka, Spyridoula</au><au>Singh-Ospina, Naikky V.</au><au>Brito, Juan P.</au><au>Gonzalez-Gonzalez, Jose G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intensive vs. conventional blood pressure goals in older patients with type 2 diabetes: a systematic review and meta-analysis</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><date>2022-10-01</date><risdate>2022</risdate><volume>78</volume><issue>1</issue><spage>13</spage><epage>23</epage><pages>13-23</pages><issn>1559-0100</issn><issn>1355-008X</issn><eissn>1559-0100</eissn><abstract>Purpose Assess the effect of intensive vs conventional blood pressure goals on patient-important outcomes in older adults with type 2 diabetes. Methods A comprehensive search was performed using electronic databases. Randomized controlled trials comparing intensive vs conventional blood pressure goals in adults over 60 years of age with type 2 diabetes were included. Events were evaluated using a modified Mantel-Haenszel meta-analysis with Peto’s method. Study selection and data extraction were performed independently and in duplicate. Results Seven trials were included. A 19% risk reduction (OR 0.81; 95% CI 0.69–0.95; I 2  = 8%; p  = 0.35) in the occurrence of major adverse cardiovascular events (MACE) and 37% risk reduction (OR 0.63; 95% CI 0.51–0.79; I 2  = 0%; p  = 0.56) in the occurrence of fatal or non-fatal stroke was documented in the intensive treatment group. There were no differences in the occurrence of all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, and peripheral vascular disease. Data regarding treatment adverse effects and microvascular outcomes was scarce. Conclusions Intensive blood pressure goals in older patients with diabetes were associated with a lower risk of stroke and MACE, but not with all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, and peripheral vascular disease. Highlights This is the first review on the effect of intensive blood pressure goals in older patients who have diabetes. This analysis provides evidence that intensive blood pressure goals in older patients with diabetes are associated with a lower risk of stroke and MACE. There were no differences in all-cause mortality, CV mortality, non-fatal myocardial infarction, and peripheral vascular disease. The pros and cons of an intensive approach should be discussed with patients given that it could increase the number of medications, cost, and adverse events. Clinicians should address these results with caution, as the estimates are not robust enough to recommend a specific blood pressure goal due to the heterogeneity of goals and interventions among the included studies.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s12020-022-03159-9</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1559-0100
ispartof Endocrine, 2022-10, Vol.78 (1), p.13-23
issn 1559-0100
1355-008X
1559-0100
language eng
recordid cdi_proquest_miscellaneous_2702183438
source Springer Nature - Complete Springer Journals
subjects Blood pressure
Cardiovascular diseases
Cerebral infarction
Clinical trials
Diabetes
Diabetes mellitus (non-insulin dependent)
Endocrinology
Heart attacks
Humanities and Social Sciences
Internal Medicine
Medicine
Medicine & Public Health
Meta-Analysis
Microvasculature
Mortality
multidisciplinary
Myocardial infarction
Patients
Science
Stroke
Vascular diseases
title Intensive vs. conventional blood pressure goals in older patients with type 2 diabetes: a systematic review and meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T18%3A16%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intensive%20vs.%20conventional%20blood%20pressure%20goals%20in%20older%20patients%20with%20type%202%20diabetes:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=Endocrine&rft.au=Rodriguez-Gutierrez,%20Rene&rft.date=2022-10-01&rft.volume=78&rft.issue=1&rft.spage=13&rft.epage=23&rft.pages=13-23&rft.issn=1559-0100&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-022-03159-9&rft_dat=%3Cproquest_cross%3E2702183438%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2714730092&rft_id=info:pmid/&rfr_iscdi=true